Unveiling the Future: A Recap of Lincoln National Corporation’s Q3 2024 Earnings Call

Lincoln Financial Corporation Q3 2024 Earnings Conference Call Overview Company Participants Tina Madon – SVP, Head of IR Ellen G. Cooper – Chairman, President, and CEO Christopher Neczypor – EVP and CFO Conference Call Participants Suneet Kamath – Jefferies Elyse Greenspan – Wells Fargo Securities Daniel Bergman – TD Cowen Operator: Good morning and thank…

Read More

Meet Tomya Watt: The Heart and Soul Behind AMN Healthcare’s People-Centric Approach

Meet Tomya Watt: The Heart and Soul Behind AMN Healthcare’s People-Centric Approach DALLAS, Oct. 31, 2024 (GLOBE NEWSWIRE) — AMN Healthcare (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations, today announced the appointment of Tomya Watt as Chief People Officer effective January 13, 2025. Embracing a People-Centric Approach When it…

Read More

Unlocking the Potential: Top U.S. Marijuana Penny Stocks to Keep an Eye on in November

Marijuana Penny Stocks: A Rising Trend in the U.S. Cannabis Industry Understanding the Growth Potential With the U.S. cannabis industry experiencing steady growth, marijuana penny stocks have gained significant attention among investors. The industry generated over $25 billion in sales in 2023 and is projected to reach $45 billion by 2025, driven by ongoing legalization…

Read More

TotalEnergies’ Q3 2024 Earnings Call: A Peek Behind the Curtain (with Some Laughs and Real Talk)

Welcome to the TotalEnergies Third Quarter 2024 Results Conference Call! Leading the Way with a Quirky Twist Hey there, fellow finance enthusiasts and TotalEnergies followers! Today, we are diving into the nitty-gritty details of the TotalEnergies Third Quarter 2024 Results Conference Call. But hold on to your seats, because we are going to approach this…

Read More

Unlocking Growth Potential: Exelixis’ Cabometyx Leads Revenue as Zanzalintinib Emerges as Future Engine

Exelixis’s Cabometyx Driving Revenue Growth and Outlook for 2024 Expanding Oncology Portfolio and Shareholder-Friendly Initiatives Exelixis recently announced that their flagship drug, Cabometyx, continues to drive revenue growth, leading to a raised 2024 revenue forecast of $2.15–$2.2 billion. This positive news comes as the company plans to diversify its oncology portfolio by launching one new…

Read More

Quantum eMotion Corp. Showcased in Prominent Korean Business Newspaper for Cutting-Edge IoT Security Solutions

Quantum eMotion Corp. Featured in Korea Business Herald’s Latest Column Introduction Quantum eMotion Corp. (TSXV: QNC) proudly announces its feature in the latest column of the Korea Business Herald, one of Asia’s most influential business publications. The article, written by Arthur Herman, senior fellow at the Hudson Institute and Director of the Quantum Alliance Initiative,…

Read More

F3 Successfully Closes Private Placement, Raising C$8 Million in Gross Proceeds

Kelowna, British Columbia: F3 Uranium Corp Announces Successful Closing of Private Placement Exciting News for F3 Uranium Corp Kelowna, British Columbia–(Newsfile Corp. – October 31, 2024) – F3 Uranium Corp. (TSXV: FUU) (OTC Pink: FUUFF) (“F3 Uranium” or the “Company”) is pleased to announce the closing of its previously announced “bought deal” private placement (the…

Read More